Alpha 2.0
Login Register
» Articles » PMID: 18305557

ETV6 Mutations and Loss in AML-M0

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2008 Feb 29
PMID 18305557
Citations 9
Authors
F P G Silva
B Morolli
C T Storlazzi
A Zagaria
L Impera
B Klein
H Vrieling
H C Kluin-Nelemans
M Giphart-Gassler
Affiliations
Soon will be listed here.
Citing Articles

Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.

Papadopoulou V, Schoumans J, Scarpelli I, Blum S Acta Haematol. 2023; 146(5):401-407.

PMID: 36848872 PMC: 10614221. DOI: 10.1159/000529844.

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Mueller S, Dal Cin P, Le L, Dias-Santagata D, Lennerz J, Iafrate A Blood Adv. 2021; 6(3):818-827.

PMID: 34587239 PMC: 8945303. DOI: 10.1182/bloodadvances.2021005280.

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.

Tien F, Hou H, Tsai C, Tang J, Chiu Y, Chen C Blood Cancer J. 2018; 8(9):87.

PMID: 30190467 PMC: 6127202. DOI: 10.1038/s41408-018-0123-2.

Germline ETV6 mutations and predisposition to hematological malignancies.

Feurstein S, Godley L Int J Hematol. 2017; 106(2):189-195.

PMID: 28555414 DOI: 10.1007/s12185-017-2259-4.

Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Feurstein S, Rucker F, Bullinger L, Hofmann W, Manukjan G, Gohring G BMC Genomics. 2014; 15:784.

PMID: 25213837 PMC: 4168160. DOI: 10.1186/1471-2164-15-784.